Idebenone protects against doxorubicin-induced cardiac injury by inhibiting ferroptosis in cardiomyocytes
{{output}}
Heart failure (HF) remains a global health challenge with limited efficacious therapies, necessitating novel strategies targeting its underlying pathological mechanisms. Emerging evidence implicates dysregulated iron metabolism and ferroptosis-an iron-dependen... ...
